Decreased Serum Retinoic Acid May Predict Poor Outcome in Ischemic Stroke Patients.

Abstract

BACKGROUND AND AIMS:

Decreased serum retinoic acid (RA) levels have been shown to be linked with increased mortality in cardiovascular diseases. This study aimed to investigate the relationship between serum RA and 3-month functional outcome after ischemic stroke.

METHODS:

Between January 2019 and September 2019, we prospectively recruited ischemic stroke patients within 24 hrs of symptom onset. Serum RA levels were measured for all patients at admission. The primary outcome was defined as poor functional outcome (modified Rankin Scale 3-6) at 90 days. The secondary outcome was defined as early neurological deterioration (END), which is considered as an increase of ≥1 point in motor power or total National Institutes of Health Stroke Scale score of ≥2 points within 7 days.

RESULTS:

A total of 217 patients were included in the analysis. The median RA levels were 2.9 ng/mL. Ninety-four (43.3%) and 65 (30.0%) patients experienced 3-month poor outcome and END, respectively. After adjusted for potential confounders, decreased levels of serum RA were associated with a higher risk of poor outcome (P for trend = 0.001) and END (P for trend = 0.002). Adding RA quartile to the existing risk factors improved risk prediction for poor outcome [net reclassification improvement (NRI) = 42.6%, P = 0.001; integrated discrimination improvement (IDI) = 5.7%, P = 0.001] and END (NRI index = 45.4%, P = 0.001; IDI = 4.3%; P = 0.005).

CONCLUSION:

Low serum RA levels at baseline were associated with poor prognosis at 90 days after ischemic stroke, suggesting that RA may be a potential prognostic biomarker for ischemic stroke.

• Authors: Mengshi Xu, Liang Xu, Huaping Du, Wanying Shan, Jie Feng, Guojie Zhai, Xiuyan Yang
• Journal: Neuropsychiatric disease and treatment (Neuropsychiatr Dis Treat) Vol. 16 Pg. 1483-1491 ( 2020) ISSN: 1176-6328 [Print] New Zealand
• PMID: 32606701 (Publication Type: Journal Article)
• Copyright: © 2020 Xu et al.